These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 839571)
1. Chemoattractant properties of Corynebacterium parvum and pyran copolymer for human monocytes and neutrophils. Majeski JA; Stinnett JD J Natl Cancer Inst; 1977 Mar; 58(3):781-3. PubMed ID: 839571 [TBL] [Abstract][Full Text] [Related]
2. Monocyte and neutrophil chemotactic activity of normal and diluted human serum and plasma. Jungi TW Int Arch Allergy Appl Immunol; 1977; 53(1):18-28. PubMed ID: 838512 [TBL] [Abstract][Full Text] [Related]
3. Monocyte function in patients with solid neoplasms during immunotherapy with Corynebacterium parvum. Scheinberg MA; Masuda A; Maluf JA; Mendes NF Cancer; 1978 May; 41(5):1761-4. PubMed ID: 647625 [TBL] [Abstract][Full Text] [Related]
4. Effect of immunomodulators on effector cells involved in antibody-dependent cellular cytotoxicity: Brief communication. Tagliabue A; Mantovani A; Polentarutti N; Vecchi A; Spreafico F J Natl Cancer Inst; 1977 Sep; 59(3):1019-22. PubMed ID: 894742 [TBL] [Abstract][Full Text] [Related]
5. Subcutaneous Corynebacterium parvum in bladder cancer: a controlled study of its immunological effects. Purves EC; Snell M; Cope WA; Addison IE; Copland RF; Berenbaum MC Br J Urol; 1979 Aug; 51(4):278-82. PubMed ID: 380732 [TBL] [Abstract][Full Text] [Related]
6. Effect of immunomodulators on thymocyte suppressive activity in mice. Anaclerio A; Conti G; Moras ML; Maconi A; Spreafico F Eur J Cancer (1965); 1978 Aug; 14(8):829-35. PubMed ID: 28950 [No Abstract] [Full Text] [Related]
7. Non-cytotoxic activity of pyran copolymer-induced macrophages associated with potentiation of tumour vaccine in recipient mice. Kataoka T; Oh-hashi F Cancer Immunol Immunother; 1985; 20(1):69-74. PubMed ID: 2998590 [TBL] [Abstract][Full Text] [Related]
8. Role of inflammatory neutrophils in antitumor effects induced by intraperitoneal administration of Corynebacterium parvum in mice. Lichtenstein AK; Berek J; Kahle J; Zighelboim J Cancer Res; 1984 Nov; 44(11):5118-23. PubMed ID: 6488171 [TBL] [Abstract][Full Text] [Related]
9. Role of anaerobic coryneforms in specific and non-specific immunological reactions. II. Production of a chemotactic factor specific for macrophages. Wilkinson PC; O'Neill GJ; Wapshaw KG Immunology; 1973 Jun; 24(6):997-1006. PubMed ID: 4197975 [TBL] [Abstract][Full Text] [Related]
10. In vitro generation of procoagulant activity by Corynebacterium parvum-stimulated mononuclear leukocytes. Miragliotta G; Marcuccio C; Ricci G; Barone G; Fumarola D J Leukoc Biol; 1985 Jan; 37(1):101-8. PubMed ID: 3880801 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of various immunomodulators: independence from normal levels of circulating monocytes and natural killer cells. Morahan PS; Dempsey WL; Volkman A; Connor J Infect Immun; 1986 Jan; 51(1):87-93. PubMed ID: 2416693 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of a tumor allograft in BALB/c x DBA/2 F1 mice by pyran copolymer. Mohr SJ; Chirigos MA; Fuhrman F; Smith G Cancer Res; 1976 Apr; 36(4):1315-9. PubMed ID: 1260757 [TBL] [Abstract][Full Text] [Related]
13. Susceptibility of Propionibacterium acnes to killing and degradation by human neutrophils and monocytes in vitro. Webster GF; Leyden JJ; Musson RA; Douglas SD Infect Immun; 1985 Jul; 49(1):116-21. PubMed ID: 2989178 [TBL] [Abstract][Full Text] [Related]
14. Activation of the classical and alternate pathways of complement by Corynebacterium parvum. McBride WH; Weir DM; Kay AB; Pearce D; Caldwell JR Clin Exp Immunol; 1975 Jan; 19(1):143-7. PubMed ID: 1204238 [TBL] [Abstract][Full Text] [Related]
15. Activation of human monocytes by mediators from lymphocytes stimulated with Corynebacterium parvum. Hammerström J; Unsgaard G; Lamvik J Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):167-75. PubMed ID: 484237 [TBL] [Abstract][Full Text] [Related]
16. Depression of hepatic biotransformations by chemical immunoadjuvants. Giampietri A; Puccetti P; Contessa AR J Immunopharmacol; 1981; 3(2):251-64. PubMed ID: 7338632 [TBL] [Abstract][Full Text] [Related]
17. Macrophage activation and increased resistance to infection in immunosuppressed mice treated with Corynebacterium parvum vaccine or pyran copolymer. Stinnett JD; Morris MJ; Alexander JW J Reticuloendothel Soc; 1979 May; 25(5):525-31. PubMed ID: 458782 [No Abstract] [Full Text] [Related]
18. Monocytes and macrophages in malignant melanoma IV. Effects of C. parvum on monocyte function. Hedley DW; Nyholm RE; Currie GA Br J Cancer; 1979 May; 39(5):558-65. PubMed ID: 486312 [TBL] [Abstract][Full Text] [Related]
19. Chemotactic efficiency of various chemoattractants for polymorphonuclear leukocytes in inflammatory acne vulgaris. Knop J; Bossecker T; Kövary PM Arch Dermatol Res; 1982; 274(3-4):267-75. PubMed ID: 6219635 [TBL] [Abstract][Full Text] [Related]
20. Effects of Legionella pneumophila sonicate on human neutrophil granulocyte and monocyte chemotaxis. Rechnitzer C; Kharazmi A; Nielsen H Eur J Clin Invest; 1986 Oct; 16(5):368-75. PubMed ID: 3100304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]